1. Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival 
Pamela Samson, MD, MPHS, Traves Crabtree, MD, Stephen Broderick, MD, Daniel Kreisel, MD, PhD, A. Sasha Krupnick, MD, G. Alexander Patterson, MD, Bryan Meyers, MD, MPH, Varun Puri, MD, MSCI 
The Annals of Thoracic Surgery 
Volume 103, Issue 1, Pages (January 2017)
DOI: /j.athoracsur
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Consolidated Standards of Reporting Trials (CONSORT) diagram for clinical stage I non-small cell lung cancer (NSCLC) patients who underwent surgical resection from 2004 to 2013, reported in the National Cancer Database (NCDB). (QM = quality measure.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Proportion of clinical stage I non-small cell lung cancer (NSCLC) patients meeting all four quality measures (QMs) over time (p < 0.001, χ2 analysis).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Kaplan-Meier analysis for clinical stage I non-small cell lung cancer (NSCLC) patients, by number of quality measures (QMs) met.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions